I would not be surprised in the least once the hol
Post# of 148177
Dr. Arman is leaving some doors cracked open. When asked about Bruce's patents he said, "Additionally, we do have other Covid related IPs that would protect leronlimab if we were to choose to do anything in that space in the near term. With regard to the NIH grant, our priority really is to complete our submission of all of our documentation for lifting the clinical hold before we would pursue any NIH opportunities for Covid."